Assessment of effect of valerian on lrritable Bowel Syndrome (IBS)
Phase 2
Recruiting
- Conditions
- Irritable bowel syndrome.Irritable bowel syndrome
- Registration Number
- IRCT20160813029327N21
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patients with irritable bowel syndrome based on Rome IV criteria
Age between 18-65 years old
Informed consent
Exclusion Criteria
Pregnant women
Lactating women
Having liver and kidney failure
Having an allergy or previous side effects to Valerian
Having diabetes
People receiving neuroleptics
People taking valerian other than our study program
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Abdominal Pain (Severity of pain and Duration of pain). Timepoint: Before intervention and 4 weeks after intervention. Method of measurement: Irritable Bowel Severity Scale (IBSS).;Abdominal distension (Bloating, Swollen or Tight tummy). Timepoint: Before intervention and 4 weeks after intervention. Method of measurement: Irritable Bowel Severity Scale (IBSS).;Satisfaction with fecal excretion. Timepoint: Before intervention and 4 weeks after intervention. Method of measurement: Irritable Bowel Severity Scale (IBSS).;The impact of the IBS on the Patient's Quality of Life. Timepoint: Before intervention and 4 weeks after intervention. Method of measurement: Irritable Bowel Severity Scale (IBSS).;Irritable Bowel Syndrome Severity Score. Timepoint: Before intervention and 4 weeks after intervention. Method of measurement: Irritable Bowel Severity Scale (IBSS).
- Secondary Outcome Measures
Name Time Method